Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says

Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet